STT News Alert State Street Corp (STT) 75.24 12/12/2014 23:1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
State Street Corp (STT) 75.24 $STT

Bank Stock Roundup: Capital Surcharge & Q4 Outlook Raise Concerns; Citi, BofA & JPMorgan in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 10:05AM CST
Overall, the performance of banking stocks remained skewed toward the pessimistic side with muted trading outlooks and legal expenses shaking investors' confidence. Further, the additional capital surcharge requirement added fuel to the fire.
STT: 75.24 (-2.96), JPM: 60.04 (-1.10), C: 53.40 (-1.11), MTB: 121.85 (-2.13), BAC: 17.13 (-0.34), WFC: 53.70 (-0.73), BK: 39.92 (-0.62)

State Street Appoints William C. Freda to its Board of Directors
Business Wire - Fri Dec 12, 7:30AM CST
State Street Corporation (NYSE:STT) today announced the appointment of William C. Freda (Bill), retired senior partner and vice chairman of Deloitte LLP, to its board of directors.
STT: 75.24 (-2.96)

State Street announces dividend of USD0.30 per share for quarter
M2 - Fri Dec 12, 6:56AM CST
State Street Corporation (NYSE:STT), a provider of financial services, reported on Friday that it will pay a common stock cash dividend of USD0.30 per share for the quarter.
STT: 75.24 (-2.96)

What Bank Stocks Are Expected To Outperform In 2015?
at Investor's Business Daily - Thu Dec 11, 3:55PM CST
Rising interest rates and better market and lending conditions bode well for the U.S. banking sector in 2015, though regulatory and legal headwinds will persist, said financial services specialist Keefe, Bruyette & Woods in a banking outlook report...
SF: 49.10 (-0.90), STT: 75.24 (-2.96), GS: 188.82 (-4.72), TLMR: 14.08 (-0.30), JPM: 60.04 (-1.10), HBAN: 10.06 (-0.19), WAL: 26.52 (-0.44), PVTB: 31.34 (-0.52), C: 53.40 (-1.11), EGBN: 34.19 (-0.88), STI: 40.23 (-0.79), WFC: 53.70 (-0.73), BAC: 17.13 (-0.34), FRME: 21.77 (-0.32), SBNY: 118.89 (-1.82)

State Street declares $0.30 dividend
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 3:30PM CST

STT: 75.24 (-2.96)

State Street Corporation Declares Quarterly Dividend on Its Common Stock
Business Wire - Thu Dec 11, 3:18PM CST
State Street Corporation (NYSE:STT) today declared a quarterly cash dividend of $0.30 per share of common stock, payable January 16, 2015 to common shareholders of record as of January 2, 2015.
STT: 75.24 (-2.96)

State Street Global Advisors Launches First Low Carbon ETF
Business Wire - Thu Dec 11, 7:31AM CST
State Street Global Advisors (SSGA), the asset management arm of State Street Corporation (NYSE:STT), today announced the SPDR MSCI ACWI Low Carbon Target ETF (Symbol: LOWC) began trading on the NYSE Arca on November 26, 2014. Developed in conjunction with the United Nations Joint Staff Pension Fund (UNJSPF), LOWC is a new vehicle that seeks to provide access to the potentially long-term growth opportunities of companies that are carbon efficient while reducing exposure to assets vulnerable to the transition to a low carbon economy.
STT: 75.24 (-2.96), LOWC: 71.94 (-1.44)

Banks May Face Additional Capital Surcharge: Time to Shrink? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 4:34PM CST
We believe that an additional capital cushion will likely lower the banks' lending ability and put pressure on revenues, thereby leading to lower earnings. Hence, these banks will have no other option but to shrink or break up their global operations.
GS: 188.82 (-4.72), STT: 75.24 (-2.96), JPM: 60.04 (-1.10), C: 53.40 (-1.11), BAC: 17.13 (-0.34), WFC: 53.70 (-0.73), BK: 39.92 (-0.62), MS: 36.25 (-1.15)

The Fed's Tough Capital Plan Focuses on Short-term Funding
at The Street - Wed Dec 10, 8:45AM CST
Big banks need to raise $21 billion.
STT: 75.24 (-2.96), GS: 188.82 (-4.72), JPM: 60.04 (-1.10), C: 53.40 (-1.11), WFC: 53.70 (-0.73), BAC: 17.13 (-0.34), BK: 39.92 (-0.62), MS: 36.25 (-1.15)

Today's Market: The Fed To Impact These Banks With New Rules
Matthew Smith - at Seeking Alpha - Wed Dec 10, 8:31AM CST

STT: 75.24 (-2.96), GS: 188.82 (-4.72), QQQ: 102.67 (-1.13), JPM: 60.04 (-1.10), C: 53.40 (-1.11), WFC: 53.70 (-0.73), BAC: 17.13 (-0.34), BK: 39.92 (-0.62), MS: 36.25 (-1.15)

Beware Weak Q4 Trading Revenue, BofA CEO Warns
at Investor's Business Daily - Tue Dec 09, 12:11PM CST
Bank of America's (BAC) chief executive warned investors to expect lower trading revenue in the fourth quarter compared to Q3 and a year earlier, sending the bank's shares falling. BofA CEO Brian Moynihan shared the information at an industry...
STT: 75.24 (-2.96), GS: 188.82 (-4.72), JPM: 60.04 (-1.10), C: 53.40 (-1.11), WFC: 53.70 (-0.73), BAC: 17.13 (-0.34), BK: 39.92 (-0.62), MS: 36.25 (-1.15)

Hit The Road, State Street
Craig Pirrong - at Seeking Alpha - Mon Dec 08, 1:27PM CST
Following the lead of Bank of New York (NYSE: BK ), State Street (NYSE: STT ) announced that it is exiting the swaps clearing business : State Street Corp. is closing down its swaps business after clients said new regulations steered them away for...
STT: 75.24 (-2.96), BK: 39.92 (-0.62)

15.1% Return Seen to Date on SmarTrend State Street Call (STT)
Comtex SmarTrend(R) - Mon Dec 08, 9:46AM CST
SmarTrend identified an Uptrend for State Street (NYSE:STT) on October 23rd, 2014 at $68.95. In approximately 2 months, State Street has returned 15.07% as of today's recent price of $79.34.
STT: 75.24 (-2.96)

Banks: "Your money's no good here"
Seeking Alpha - at Seeking Alpha - Mon Dec 08, 9:28AM CST

STT: 75.24 (-2.96), JPM: 60.04 (-1.10), C: 53.40 (-1.11), DB: 30.78 (-0.56), HSBC: 47.38 (-0.90), BAC: 17.13 (-0.34), BK: 39.92 (-0.62)

State Street Global Advisors: A Divergent World Creates Opportunities in 2015
Business Wire - Mon Dec 08, 6:00AM CST
State Street Global Advisors (SSGA), the asset management arm of State Street Corporation (NYSE: STT), today announced that its global market outlook for 2015 anticipates that diverging global monetary policy will have an impact on every asset class, but poses interesting and diverse opportunities for proactive investors.
STT: 75.24 (-2.96)

Financial sector leads the way on strong jobs number
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 9:06AM CST

UYG: 141.66 (-5.65), KBE: 32.58 (-0.48), RF: 10.01 (-0.16), BBT: 37.45 (-0.73), HBAN: 10.06 (-0.19), PRU: 86.66 (-3.13), BNY: 14.23 (+0.07), C: 53.40 (-1.11), QABA: 35.24 (-0.47), KEY: 13.30 (-0.23), KRE: 39.10 (-0.54), JPM: 60.04 (-1.10), RKH: 54.67 (-1.50), FNCL: 28.43 (-0.49), FXO: 22.67 (-0.45), ETFC: 22.58 (-0.94), KIE: 65.06 (-1.40), FAS: 117.50 (-7.45), XLF: 24.14 (-0.48), FAZ: 13.92 (+0.74), RYF: 43.55 (-0.84), ZION: 26.98 (-0.43), SCHW: 28.75 (-0.93), FINZ: 24.28 (unch), SEF: 18.08 (+0.31), STT: 75.24 (-2.96), VFH: 48.60 (-0.90), KRS: 28.13 (+1.10), KBWB: 37.03 (-0.71), FINU: 80.97 (-4.77), KRU: 85.15 (-2.89), MET: 52.82 (-2.39), WFC: 53.70 (-0.73), BAC: 17.13 (-0.34), IYG: 89.32 (-1.85), LNC: 55.01 (-1.93), IYF: 88.10 (-1.71), KBWI: 70.00 (unch), NTRS: 65.90 (-0.96), IAK: 48.68 (-1.12), KBWR: 38.45 (-0.65), RWW: 49.09 (-1.22), IAI: 40.94 (-1.13), KBWP: 42.24 (-0.31), IAT: 33.83 (-0.53), PSCF: 40.50 (-0.50), AMTD: 34.92 (-1.17)

State Street Global Exchange Announces Collaboration with Josh Lerner and the Private Capital Research Institute to Enhance Private Equity Research
Business Wire - Thu Dec 04, 12:00PM CST
State Street Global Exchange today announced a new collaboration with Josh Lerner, Jacob H. Schiff professor of investment banking at Harvard Business School, and the Private Capital Research Institute (PCRI) that seeks to further academic research on private capital. Also announced today is the launch of the GX Private Equity Index portal which will provide State Street clients with enhanced transparency into private capital market performance, trends and liquidity via a web-based application.
STT: 75.24 (-2.96)

BofA's Cost-Saving Initiatives on Track: Should You Invest? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 9:50AM CST
We believe that BofA's efficiency initiative - Project New BAC - will continue to support its financials, as revenue growth is expected to remain muted in the near term.
PFBC: 25.31 (-0.57), STT: 75.24 (-2.96), WAL: 26.52 (-0.44), BAC: 17.13 (-0.34)

Bank of New York Mellon Cedes Board Seat to Trian Fund
at The Street - Wed Dec 03, 8:39AM CST
Nelson Peltz will relinquish his seat at Legg Mason after placing a lieutenant on the New York lender's expanded board.
STT: 75.24 (-2.96), LM: 50.28 (-1.73), BK: 39.92 (-0.62)

U.S. Banks with Growth Potential - Industry Outlook
Kalyan Nandy - Zacks Investment Research - Wed Dec 03, 12:00AM CST
U.S. Banks with Growth Potential - Industry Outlook
CFR: 70.00 (-1.62), LION: 15.69 (-0.13), STT: 75.24 (-2.96), STBA: 28.36 (-0.42), EFSC: 19.07 (+0.06), ORIT: 14.51 (-0.17), FCB: 24.38 (-0.07), HBNC: 24.70 (-0.14), ASBC: 18.06 (-0.26), ISTR: 14.05 (-0.01), BYLK: 12.61 (-0.04)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 337

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 296

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 416

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 195

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 271

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 267

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Mesirow Recognized Among Top Money Management Workplaces Again

Updated Category News Views 156

Mesirow's Remarkable Recognition in Money Management Mesirow has just been honored by Pensions & Investments as a Best Places to Work in Money Management for the year 2025, marking the seventh occasion the firm has received this prestigious recognition. This accolade reflects Mesirow's unwavering commitment to fostering a workplace that prioritizes culture, employee...

Continue Reading
Follett and Bath & Body Works Team Up for Campus Retail Revolution

Updated Category News Views 275

Follett Higher Education Partners with Bath & Body Works This happy collaboration marks Follett Higher Education's new venture to enrich student life on college campuses across the nation. Follett, recognized as North America's largest campus retailer, is working with Bath & Body Works to bring their beloved bath and body products directly to students at more than 150...

Continue Reading
Understanding Recent Share Transactions of Planisware SA

Updated Category News Views 125

Overview of Planisware's Recent Share Transactions Planisware SA has recently undergone several notable transactions concerning its own shares. As a leader in project portfolio management software, the company's activities on the share market reflect its strong position and proactive approach in satisfying investor interests. Company Details Planisware SA is widely...

Continue Reading
Investor Alert: Lawsuit Against Iris Energy Limited Explained

Updated Category News Views 112

Overview of the Investor Lawsuit Against Iris Energy Limited The legal landscape for investors can often be complex, especially when serious allegations are involved. Recently, the national securities law firm, Faruqi & Faruqi, LLP, has initiated an investigation targeting Iris Energy Limited (NASDAQ: IREN) concerning potential securities law violations. The firm is...

Continue Reading
Warner Bros. Discovery Welcomes Anton Levy to Board

Updated Category News Views 166

Warner Bros. Discovery Welcomes Anton Levy to the Board Warner Bros. Discovery, Inc. (NASDAQ: WBD) is thrilled to announce the upcoming addition of Anton Levy to its Board of Directors as an independent member. This decision is part of the company's commitment to building a strong leadership team aimed at navigating the evolving media landscape. Anton Levy: A Wealth of...

Continue Reading